Cargando…

AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber

We present the case of a 40-year-old male, who presented to the ophthalmology emergency department with pain and visual loss in his left eye 10 days after an intravitreal injection of a split medication. At the exploration, we found an intense corneal edema in the left eye with endothelial dusting a...

Descripción completa

Detalles Bibliográficos
Autores principales: Payá, Emma Marín, González, Marina Aguilar, Ortuño, Miriam Rahhal, Corell, Paula Martínez López, Arteaga, Jorge Vila, Llopis, Manuel Díaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Romanian Society of Ophthalmology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289775/
https://www.ncbi.nlm.nih.gov/pubmed/35935083
http://dx.doi.org/10.22336/rjo.2022.37
_version_ 1784748742113492992
author Payá, Emma Marín
González, Marina Aguilar
Ortuño, Miriam Rahhal
Corell, Paula Martínez López
Arteaga, Jorge Vila
Llopis, Manuel Díaz
author_facet Payá, Emma Marín
González, Marina Aguilar
Ortuño, Miriam Rahhal
Corell, Paula Martínez López
Arteaga, Jorge Vila
Llopis, Manuel Díaz
author_sort Payá, Emma Marín
collection PubMed
description We present the case of a 40-year-old male, who presented to the ophthalmology emergency department with pain and visual loss in his left eye 10 days after an intravitreal injection of a split medication. At the exploration, we found an intense corneal edema in the left eye with endothelial dusting and ciliary hyperemia. LE fundus was impracticable due to anterior chamber opacity. Because of the corneal edema, we performed an anterior segment optical coherence tomography (AS- OCT), visualizing a cyclitic membrane with pupillary block and inflammatory cells in the anterior chamber. There are different treatments to lyse the cyclitic membrane; in this case, we managed the cyclitic membrane with 0,05 ml of intracameral recombinant tissue plasminogen activator (rtPA), a highly potent fibrinolytic protein. We disinfected the eyelids and the conjunctival sac with Povidone Iodine solution, applied topical anesthesia with double anesthetic, and injected 0,05 mL rtPA solution into the anterior chamber using an insulin syringe with a 30-gauge needle. Intracameral rtPA was prepared under sterile conditions using 50 mg vials of rtPA diluted with 50 mL of sterile water to create a 1 mg/ mL solution. Four hours after rtPA treatment, the cyclitic membrane lysed, obtaining pupillary mydriasis. The AS OCT before and after the treatment with intracameral rtPA was of high utility as it allowed the visualization of the cyclitic membrane and its removal.
format Online
Article
Text
id pubmed-9289775
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Romanian Society of Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-92897752022-08-04 AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber Payá, Emma Marín González, Marina Aguilar Ortuño, Miriam Rahhal Corell, Paula Martínez López Arteaga, Jorge Vila Llopis, Manuel Díaz Rom J Ophthalmol Case Reports We present the case of a 40-year-old male, who presented to the ophthalmology emergency department with pain and visual loss in his left eye 10 days after an intravitreal injection of a split medication. At the exploration, we found an intense corneal edema in the left eye with endothelial dusting and ciliary hyperemia. LE fundus was impracticable due to anterior chamber opacity. Because of the corneal edema, we performed an anterior segment optical coherence tomography (AS- OCT), visualizing a cyclitic membrane with pupillary block and inflammatory cells in the anterior chamber. There are different treatments to lyse the cyclitic membrane; in this case, we managed the cyclitic membrane with 0,05 ml of intracameral recombinant tissue plasminogen activator (rtPA), a highly potent fibrinolytic protein. We disinfected the eyelids and the conjunctival sac with Povidone Iodine solution, applied topical anesthesia with double anesthetic, and injected 0,05 mL rtPA solution into the anterior chamber using an insulin syringe with a 30-gauge needle. Intracameral rtPA was prepared under sterile conditions using 50 mg vials of rtPA diluted with 50 mL of sterile water to create a 1 mg/ mL solution. Four hours after rtPA treatment, the cyclitic membrane lysed, obtaining pupillary mydriasis. The AS OCT before and after the treatment with intracameral rtPA was of high utility as it allowed the visualization of the cyclitic membrane and its removal. Romanian Society of Ophthalmology 2022 /pmc/articles/PMC9289775/ /pubmed/35935083 http://dx.doi.org/10.22336/rjo.2022.37 Text en © The Authors.Romanian Society of Ophthalmology https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Payá, Emma Marín
González, Marina Aguilar
Ortuño, Miriam Rahhal
Corell, Paula Martínez López
Arteaga, Jorge Vila
Llopis, Manuel Díaz
AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber
title AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber
title_full AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber
title_fullStr AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber
title_full_unstemmed AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber
title_short AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber
title_sort as-oct of cyclitic membrane pre and post treatment with rtpa in the anterior chamber
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289775/
https://www.ncbi.nlm.nih.gov/pubmed/35935083
http://dx.doi.org/10.22336/rjo.2022.37
work_keys_str_mv AT payaemmamarin asoctofcycliticmembranepreandposttreatmentwithrtpaintheanteriorchamber
AT gonzalezmarinaaguilar asoctofcycliticmembranepreandposttreatmentwithrtpaintheanteriorchamber
AT ortunomiriamrahhal asoctofcycliticmembranepreandposttreatmentwithrtpaintheanteriorchamber
AT corellpaulamartinezlopez asoctofcycliticmembranepreandposttreatmentwithrtpaintheanteriorchamber
AT arteagajorgevila asoctofcycliticmembranepreandposttreatmentwithrtpaintheanteriorchamber
AT llopismanueldiaz asoctofcycliticmembranepreandposttreatmentwithrtpaintheanteriorchamber